Improving the care of patients with cancer with better stratification and improved treatment selection, as well as identifying ineffective treatments early so they can be changed ‐ including:

  • Can novel PET/MRI and statistical learning methodologies characterise cancer heterogeneity and personalise likely treatment response to drugs/radiotherapy?
  • Can the non‐invasive concept of magnetic force imaging characterise the metastatic potential of tumours?
  • Can we image and track the modified immune therapeutic cells we inject in cancer to make sure they are working effectively in individual patients?